Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa BI for Acute Bleeding in Hemophilia With Inhibitors
NCT01757405Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2013
- Primary completion
- Nov 2014
- Countries
- 9
01
Overview
A Phase 3 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by Takeda. Started Feb 2013; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT01757405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757405.